Is a complete HKPD research report available?

No complete published report is available for Cellyan Biotechnology Co., Ltd (HKPD) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Cellyan Biotechnology Co., Ltd (HKPD)

NASDAQ: HKPD · USD

$0.41

+0.01 (+3.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first HKPD analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	9.6M
Revenue (ttm)	16.4M
Net income (ttm)	-701.9K
EPS (ttm)	-$0.07
Shares out	23.5M
Volume	90,796

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 16.4M
Net income (ttm): -701.9K
EPS (ttm): -$0.07
Market cap: 9.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All HKPD indicators

Market & fundamental data

Available fields

193

Groups with data

Currency

USD

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002007702
Company name	Cellyan Biotechnology Co., Ltd
Country	Hong Kong
Country code	US
Cusip	G6365B104
Employees	27
Employees Change	8%
Employees Change Percent	42.11
Enterprise value	$9.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Distribution
Industry PE	28.62
Industry PE Fwd	18.84
IPO Date	2025-01-15
Isin	KYG6365B1041
Last refreshed	2026-07-31
Market cap	$9.6M
Market cap category	Nano-Cap
Price	$0.41
Price currency	USD
Rev Per Employee	605,917.37x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	5122
Symbol	HKPD
Website	https://www.9zt.hk

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.32%
EV/EBITDA	21.79x
EV/Sales	0.57x
FCF yield	-5.13%
P/B ratio	0.87x
P/S ratio	0.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-4.04%
EBITDA Margin	2.63%
Gross margin	8.8%
Gross Profit	$1.4M
Gross Profit Growth	-65.11%
Gross Profit Growth Q	-30.33%
Net Income	$-701,880
Net Income Growth Q	-81.45%
Net Income Growth Years	0%
Pretax Margin	-4.71%
Profit Margin	-4.29%
Profit Per Employee	$-25,996
ROA	-3.94
ROCE	-10
ROE	-13.37
ROIC	-12.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-66.03%
EPS Growth Q	-83.13
EPS Growth Years	0
Revenue Growth	-21.24x
Revenue Growth Q	-35.65x
Revenue Growth Years	2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.65
Assets	$9.6M
Cash	$2.5M
Current Assets	$8.9M
Current Liabilities	$3M
Debt	$2.3M
Debt EBITDA	$5.28
Debt Equity	$0.44
Equity	$5.1M
Interest Coverage	-5.94
Liabilities	$4.5M
Long Term Assets	$776,298
Long Term Liabilities	$1.5M
Net Cash	$208,650
Net Cash By Market Cap	$2.18
Net Debt EBITDA	$-0.48
Net Debt Equity	$-0.04
Tangible Book Value	$5.1M
Tangible Book Value Per Share	$0.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.93
Inventory Turnover	25.97
Net Working Capital	$4.2M
Quick ratio	2.51
Working Capital	$5.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.69%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-66.01%
200-day SMA	0.73
50-day SMA	0.44
50-day SMA vs 200-day SMA	50under200
All Time High	3.79
All Time High Change	-89.24%
All Time High Date	2025-01-15
All Time Low	0.31
All Time Low Change	31.58%
All Time Low Date	2026-07-22
ATR	0.06
Beta1y	1.61
Beta2y	1.28
Ch YTD	-50.52
High	0.42
High52	2.58
High52 Date	2025-08-26
High52ch	-84.19%
Low	0.39
Low52	0.31
Low52 Date	2026-07-22
Low52ch	31.58%
Ma50ch	-6.89%
Premarket Change Percent	-2.65
Premarket Price	$0.39
Premarket Volume	2,342
Price vs 200-day SMA	-43.77%
RSI	49.76
RSI Monthly	23.42
RSI Weekly	35.55
Sharpe ratio	-0.42x
Sortino ratio	-0.59
Total Return	-19.69%
Tr YTD	-50.52
Tr1m	13.31%
Tr1w	23.23%
Tr3m	-37.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-623,584
Operating Income Growth Q	-37.69
Operating margin	-3.81

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,713,668%
Float Percent	66.87%
Net Borrowing	-478,830
Shares Insiders	33.13%
Shares Institutions	0.27%
Shares Out	23,499,986
Shares Qo Q	5.66%
Shares Yo Y	19.69%
Short Float	1.14%
Short Ratio	2.96
Short Shares	0.76

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,496,417.45x
Bv Per Share	0.47
CAPEX	$-64,314
Ch1m	13.31
Ch1w	23.23
Ch1y	-66.01
Ch3m	-37.25
Ch6m	-49.05
Change	3.14%
Change From Open	4.75
Close	0.4
Days Gap	-1.54
Depreciation Amortization	89,106
Dollar Volume	37,035.7
Earnings Date	2026-08-14
Earnings Time	bmo
EBIT	$-660,681
EBITDA	$430,416
EPS	$-0.07
F Score	2
FCF	$-492,236
FCF EV Yield	-5.25x
FCF Per Share	$-0.02
Financing CF	2,637,583
Fiscal Year End	March
Founded	2,016
Income Tax	$-69,068
Investing CF	-2,391,119
Ipr	-89.8
Iprfo	-88.35
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-18
Last Report Date	2025-09-30
Last Split Type	Never
Last10k Filing Date	2025-08-14
Ma150	0.61
Ma150ch	-33.25%
Ma20	0.41
Ma20ch	-0.49%
Net CF	-174,020
Next Earnings Date	2026-08-14
Open	0.39
Optionable	No
Position In Range	55.86
Post Close	0.41
Postmarket Change Percent	0.02
Postmarket Price	$0.41
Ppne	686,080
Pre Close	0.4
Price Date	2026-07-30
Price EBITDA	$22.28
Ptbv Ratio	1.9
Relative Volume	0.06x
Revenue	16,359,769x
Tax By Revenue	-0.42x
Tr6m	-49.05%
Volume	90,796
Z Score	4.52

Cellyan Biotechnology Co., Ltd (HKPD)

Coverage state: Market snapshot only — no published research

Generate the first HKPD analysis

Price

Financial snapshot

Fair-value bridge

Latest news · HKPD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HKPD indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on HKPD

Frequently asked questions